Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b/2a, Cross-over, Randomised, Double-blind, Placebo Controlled Study to Investigate the Safety and Pharmacodynamic Effects of GET 73 in Alcohol Dependent Subjects

NCT01842503 is registered in ClinicalTrials.gov with Laboratorio Farmaceutico Ct S.r.l. as lead sponsor.

NCT NCT01842503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01842503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b/2a, Cross-over, Randomised, Double-blind, Placebo Controlled Study to Investigate the Safety and Pharmacodynamic Effects of GET 73 in Alcohol Dependent Subjects
Lead sponsor
Laboratorio Farmaceutico Ct S.r.l.
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2014
Completion date
November 30, 2018
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence